Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .

Add to Collection

2010 May-Jun Others C Wilson, CC Huang, N Shara, BV Howard… - Journal of Clinical …, 2010 - Elsevier 117

Full Author : ['Wilson, Charlton', 'Huang, Chun-Chih', 'Shara, Nawar', 'Howard, Barbara V', 'Fleg, Jerome L', 'Henderson, Jeffrey A', 'Howard, Wm James', 'Huentelman, Heather', 'Lee, Elisa T', 'Mete, Mihriye', 'Russell, Marie', 'Galloway, James M', 'Silverman, Angela', 'Stylianou, Mario', 'Umans, Jason', 'Weir, Matthew R', 'Yeh, Fawn', 'Ratner, Robert E']
Journal Title : Journal of clinical lipidology
Chapter : Section3
Journal Year : 2010
Cited by : 7.0

BACKGROUND: The Stop Atherosclerosis in Native Diabetics Study (SANDS) reported cardiovascular benefit of aggressive versus standard treatment targets for both low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP) in diabetic individuals. OB..... Read More

Keywords : ["native diabetic study sand", "lowdensity lipoprotein cholesterol", "stop atherosclerosis", "low target", "blood pressure", "diabetes", "costeffectiveness"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S1933287410000474
Google Scholar Link : https://scholar.google.com/scholar?cites=8075485771398125541&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .